| |
 |
AstraZeneca AB Patents |
|
Assignee: AstraZeneca AB
Address: Sodertalje, SE
No. of patents: 725
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| D582240 |
Blister pack device |
December 9, 2008 |
|
| D578302 |
Container device |
October 14, 2008 |
|
| D570171 |
Blister pack device |
June 3, 2008 |
|
| D565838 |
Container device |
April 8, 2008 |
|
| D561901 |
Device for communicating with a voice-disabled person |
February 12, 2008 |
|
| D546198 |
Device for holding a blister pack |
July 10, 2007 |
|
| D529605 |
Inhalation device |
October 3, 2006 |
|
| D515203 |
Inhalation device |
February 14, 2006 |
|
| D493519 |
Inhaler |
July 27, 2004 |
|
| D483861 |
Injection device with pull off strip |
December 16, 2003 |
|
| D480474 |
Inhaler |
October 7, 2003 |
|
| D473298 |
Inhaler refill |
April 15, 2003 |
|
| D461408 |
Device holder for a package |
August 13, 2002 |
|
| D458366 |
Ampoule |
June 4, 2002 |
|
| D455953 |
Blister pack |
April 23, 2002 |
|
| D455345 |
Blister pack |
April 9, 2002 |
|
| D455344 |
Blister pack |
April 9, 2002 |
|
| D455212 |
Femoral fixture for a hip joint prosthesis |
April 2, 2002 |
|
| D454781 |
Blister pack |
March 26, 2002 |
|
| D454637 |
Connector |
March 19, 2002 |
|
| D452735 |
Tie of an attachment for the trailing end of a urethral drainage tube |
January 1, 2002 |
|
| D450382 |
Catheter |
November 13, 2001 |
|
| D449882 |
Inhaler |
October 30, 2001 |
|
| D449226 |
Container for medicinal dosage forms |
October 16, 2001 |
|
| D448076 |
Inhaler |
September 18, 2001 |
|
| D447560 |
Ampoule set |
September 4, 2001 |
|
| D444225 |
Inhaler |
June 26, 2001 |
|
| D443930 |
Rectal insertion device |
June 19, 2001 |
|
| D443692 |
Abutment for temporary dental prosthesis |
June 12, 2001 |
|
| 7618993 |
Compounds |
November 17, 2009 |
| The present invention relates to new compounds ##STR00001## or salts, solvates or solvated salts thereof, processes for their preparation and to new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and to the use of said compounds |
| 7615642 |
Therapeutic compounds |
November 10, 2009 |
| Compounds of formula I or pharmaceutically acceptable salts thereof: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in p |
| 7615555 |
Piperidine derivatives as modulators of chemokine receptor CCR5 |
November 10, 2009 |
| Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal). ##STR00001## |
| 7615045 |
Hydrophilic urinary catheter having a water-containing sachet |
November 10, 2009 |
| A wetting apparatus (110) for wetting a hydrophilic urinary catheter (103) comprises a wetting receptacle (101) which defines a wetting fluid receiving area (102) for receiving the hydrophilic urinary catheter and a hydrophilic urinary catheter wetting fluid container (106) having a |
| 7612179 |
antibodies binding to a C-terminal fragment of apoliopoprotein E |
November 3, 2009 |
| A human antibody fragment, which antibody or fragment: (i) binds to a polypeptide having the amino acid sequence shown in SEQ ID NO: 1 of the C-terminal domain of Apolipoprotein E (ApoE-CTD) or the amino acid sequence of a part thereof; and (ii) binds to human plaques. |
| 7612077 |
Crystalline forms of the anti-cancer compound ZD1839 |
November 3, 2009 |
| The invention concerns certain crystalline solvates and hydrates of the compound of the Formula (I) which is known inter alia by way of the code number ZD1839. In particular, the invention concerns a first solvate that occurs in the presence of methanol which is designated as Form 2 ZD18 |
| 7608628 |
Alkylsulphonamide quinolines |
October 27, 2009 |
| Compounds of Formula II ##STR00001## wherein R.sup.1, A, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.8, n, m and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same. |
| 7598377 |
Inhibition of phosphoinositide 3-kinase .beta. |
October 6, 2009 |
| The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase .beta., use of the selective inhibitors in anti-thrombotic therapy, and a method for screening compounds useful for the new anti-thrombotic therapy by detecting selective inhibitory activity of PI |
| 7595321 |
Compounds having selective inhibiting effect at GSK3 |
September 29, 2009 |
| The present invention relates to new compounds of formula (I) wherein Z is N; Y is CONR.sup.5, NR.sup.5CO, SO.sub.2NR.sup.5, NR.sup.5SO.sub.2, CH.sub.2NR.sup.5, NR.sup.5, NR.sup.5CONR.sup.5, CH.sub.2CO, CO, O or CH.sub.2O; X is CH or N; P is phenyl or a 5 or 6 membered heteroaromatic |
| 7595319 |
Compounds having selective inhibiting effect at GSK3 |
September 29, 2009 |
| Selective phenyl substituted aminopyrazine inhibitors of GSK3 useful for the prevention and/or treatment of cognitive disorders. |
| 7587988 |
Inhaler device counter |
September 15, 2009 |
| Inhaler counter (20) comprising a counter housing (390), a rocker arm (200) with a pawl (210), the rocker arm being pivotally supported by the housing and arranged to perform a rocker movement in response to a linear actuation motion, a return spring (220) for resetting the rocker arm, a |
| 7585881 |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonis |
September 8, 2009 |
| The present invention relates to new compounds of formula I, ##STR00001## to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders. |
| 7585867 |
Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one |
September 8, 2009 |
| A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy. ##STR00001## |
| 7585853 |
Compounds having selective inhibiting effect at GSK3 |
September 8, 2009 |
| The present invention relates to new compounds of formula (I) wherein: Z is N and X is CH or N; Y is CONR.sup.5; P is phenyl or a 5 or 6 membered heteroaromatic ring containing one or more heteroatoms selected from N, O or S; Q is phenyl or a 5 or 6 membered aromatic heterocyclic ring |
| 7582629 |
Derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators |
September 1, 2009 |
| The present invention relates to certain novel compounds of the formula (I) to processes for preparing such compounds, to their the utility in modulation of nuclear hormone receptors Liver X Receptor (LXR) .alpha. (NR1H3) and/or .beta. (NR1H2) and in treating and/or preventing clinical |
| 7579349 |
4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
August 25, 2009 |
| A compound of Formula (I); wherein the substituents are as defined in the text for use in modulating insulin-like growth factor 1 receptor activity in a warm blooded animal such as man. ##STR00001## |
| 7579344 |
Pyrimidine derivatives possessing cell-cycle inhibitors activity |
August 25, 2009 |
| Compounds of the formula (I), and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti cell prolif |
| 7576095 |
Therapeutic agents |
August 18, 2009 |
| The present invention relates to 4,5-dihydropyrrolo[3,2-c]pyridin-4-one compounds of formula IA and processes for preparing such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods for their therapeutic use and to pharmaceutical compositio |
| 7576093 |
Method of treatment of bone-related disorders or conditions |
August 18, 2009 |
| The present invention relates to a new use of a compound of the formula (I) ##STR00001## wherein R.sub.1 is NH.sub.2, piperazin-1-yl, 4-methylpiperazin-1-yl,4-methyl-1,4-diazepan-1-yl or 4-ethylpiperazin-1-yl; R.sub.2 is hydrogen, fluoro, CH.sub.3, CH.sub.2CH.sub.3, OCH.sub.3, CF.su |
| 7576077 |
Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
August 18, 2009 |
| The present invention is directed to compounds of formula I: ##STR00001## wherein X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.5, X.sup.6, X.sup.7, X.sup.8, X.sup.9, X.sup.10, R.sup.1, R.sup.2, R.sup.3, R.sup.4, and n are as defined for formula I in the description. The invention also relat |
| 7572826 |
Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
August 11, 2009 |
| The invention relates to thiophene carboxamides of formula (I), wherein A, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy. |
|
|
|
